Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with ...

Mechanically ventilated patients’ respiratory function can be improved with pulmonary rehabilitation, especially IMT and NMES.

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

"If you speak with women who have had previous heart attacks, they will often tell you that they had spoken with their doctor ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

Tectonic Therapeutic (TECX) announced positive interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...